Rapid blood test can hasten treatment for stroke patients with brain bleeding

Blood test may detect stroke type before hospital arrival, allowing faster treatment

People with brain bleeds had nearly 7 times higher blood levels of a specific brain protein, called glial fibrillary acidic protein (GFAP), than those who had strokes caused by clots in a study conducted in Germany.

Rapid blood test can hasten treatment for stroke patients with brain bleeding

A rapid blood test could speed treatment for people who have suffered a stroke related to brain bleeding, a new study says.

Rapid Blood Test Can Improve Stroke Treatment

Key Takeaways

Rapid blood test could identify brain bleeds from clot-caused strokes

A blood test may rapidly distinguish brain bleeds from clot-caused strokes, even before people with stroke symptoms reach the emergency room, according to a preliminary study to be presented at the American Stroke Association's International Stroke Conference 2025.

Blood Test May Detect Stroke Type Before Hospital Arrival

Summary: A blood test measuring GFAP levels may help emergency responders differentiate between hemorrhagic and ischemic strokes before hospital arrival. Takeaways: GFAP as a Stroke Biomarker: The study found that glial fibrillary acidic protein (GFAP) levels were nearly seven times higher in hemorrhagic stroke patients than in those with ischemic strokes, demonstrating its potential as a rapid diagnostic tool. Prehospital Diagnosis & Treatment…

Blood Test Could Identify Stroke Type Prior to Hospital Arrival, Enabling

A groundbreaking study emerging from Germany has initiated a paradigm shift in the approach to diagnosing strokes. With stroke being one of the leading causes of death and long-term disability, clinicians are constantly seeking more efficient and effective means to identify the type of stroke a patient is experiencing. The research reveals that a blood test measuring levels of glial fibrillary acidic protein (GFAP) provides compelling insights t…